| Literature DB >> 32036600 |
Bharathi Balachander1, Deepa Rajesh1, Cycil Lillian Pinhero1, Sunu Paul1, Sophia Stevens1, Suman Rao2.
Abstract
OBJECTIVE: To analyze the infection outbreaks, control measures and outcomes of the outbreak in the NICU of a tertiary care centre in the year 2018.Entities:
Keywords: Infectious disease outbreak; Methicillin resistant Staphylococcus aureus; Multi-drug resistant Acinetobacter; Surveillance
Mesh:
Year: 2020 PMID: 32036600 PMCID: PMC7223971 DOI: 10.1007/s12098-020-03201-6
Source DB: PubMed Journal: Indian J Pediatr ISSN: 0019-5456 Impact factor: 1.967
Causative organisms, time periods and outcomes of outbreaks in the year 2018
| Time period | Total babies admitted | Patient days | Ventilator days | Organism | Isolated in | Outcome | Possible source |
|---|---|---|---|---|---|---|---|
| 1/5/18–15/5/18 | 124 | 575 | 44 | MDR Gram negative bacilli | Rectal swab/ Stool | 0 deaths | Nil identified |
| 7/8/18–25/8/18 | 66 | 371 | 116 | MRSA | Skin swab | 0 deaths 1 blood culture positive | Maternal LSCS wound infection HCP – Nasal carrier |
| 8/10/18–24/10/18 | 58 | 367 | 92 | MDR Acinetobacter | Blood | 4 deaths | Outborn infant with 1st blood culture positive |
HCP Health care personnel; LSCS Lower segment cesarean section; MDR Multi-drug resistant; MRSA Methicillin resistant Staphylococcus aureus
Characteristics of infants colonised with Rectal MDR GNB (May 2018)
| Infant no. | Organism | Resistance | Diagnosis | GA | Birth weight | Date of isolation | Day of life | Outcome |
|---|---|---|---|---|---|---|---|---|
| 1 | Klebsiella | Levofloxacin, Meropenem | RDS/ post surfactant | 28 | 1210 | 2/5/18 | 28 | Discharged |
| 2 | Klebsiella | Meropenem, Levofloxacin | RDS/ SGA/ Hypoglycemia | 35+5 | 1390 | 2/5/18 | 6 | Discharged |
| 3 | Klebsiella | Meropenem, Levofloxacin, Aztreonam, Cefipime | Very preterm/ RDS/ IDM | 31+2 | 1400 | 2/5/18 | 8 | Discharged |
| 4 | Klebsiella | Meropenem/ Levofloxacin | Anti C, anti E, Post exchange transfusion | 37+5 | 2420 | 8/5/18 | 7 | Discharged |
| 5 | Klebsiella | Meropenem/ Levofloxacin | IUGR/ RDS/perforation status ileostomy | 32+2 | 865 | 8/5/18 | 48 | Discharged |
| 6 | Klebsiella | Meropenem/ Levofloxacin | HIE 2/ Therapeutic hypothermia | 38 | 3540 | 8/5/18 | 5 | Discharged |
| 7 | Klebsiella | Meropenem, Levofloxacin, Aztreonam, Cefipime | Neonatal seizures | 39+3 | 2800 | 8/5/18 | 7 | Discharged |
| 8 | Klebsiella | Meropenem/Levoflox/cefipime | Very preterm/ RDS | 28+6 | 1500 | 8/5/18 | 6 | Discharged |
| 9 | Klebsiella | Meropenem/Levoflox/cefipime | Very preterm/ RDS/ AKI | 28+6 | 1000 | 8/5/18 | 6 | Discharged |
| Sources | HMF and probiotic sent for culture – no pathogenic organism Tap water sent for culture – no organism grown Environmental surveillance – no organism | |||||||
| Action taken | • Strengthening of hand hygiene • Cohorting and isolation of infants • ANTT for handling of milk, HMF and probiotic • Use distilled water for cleaning of diaper area • Environmental cleaning | |||||||
No MDR GNB was isolated in surveillance culture of 15/5/18
AKI Acute kidney injury; ANTT Aseptic non-touch technique; GA Gestational age; GNB Gram negative bacilli; HIE Hypoxic ischemic encephalopathy; HMF Human milk fortifier; IDM Infant of diabetic mother; IUGR Intrauterine growth restriction; MDR Multi-drug resistant; RDS Respiratory distress syndrome; SGA Small for gestational age
Characteristics of infants colonized with MRSA (7/8/18–12/8/18)
| Infant number | Organism | Diagnosis at admission | GA | Birth weight | Date of isolation | Day of life | Outcome |
|---|---|---|---|---|---|---|---|
| 1 | MRSA | Moderately PT/ SGA | 32+5 | 835 | 7/8/18 | 15 | • Maternal pus culture – MRSA • Discharged |
| 2 | MRSA | Esophageal atresia | 34+5 | 1260 | 7/8/18 | 11 | • Blood culture positive for MRSA on 12/8/18. • Treated with netilmycin. • Discharged |
| 3 | MRSA | Extreme preterm, RDS, abandoned infant | 25+3 | 730 | 7/8/18 | 41 | Discharged |
| 4 | MRSA | Moderately preterm, Abnormal Doppler | 33+5 | 1250 | 7/8/18 | 11 | Discharged |
| 5 | MRSA | Moderately PT/ VLBW | 33 | 1130 | 12/8/18 | 17 | • Pustule over forehead – MRSA • Discharged |
| 6 | MRSA | Very preterm/ RDS | 28+4 | 1320 | 21/8/18 | 8 | Discharged |
| Source | Maternal wound swab positive – MRSA Nasal swab of all HCP – 2 HCP found to be positive | ||||||
| Action | • Strengthen hand hygiene and infection control practices • Screening of healthcare personnel • Parental counseling • Hand wash is a must in the stable side cohort before exiting • Separate gown at entry to the stable side cohort • Disposal of waste inside this cohort • DO NOT mix these with other waste. • Isolation and cohort nurses to refrain from preparing IV fluids | ||||||
GA Gestational age; HCP Health care personnel; IV Intravenous; MRSA Methicillin resistant Staphylococcus aureus; PT Preterm; RDS Respiratory distress syndrome; SGA Small for gestational age; VLBW Very low birth weight
Characteristics of infants with MDR Acinetobacter (October 2018)
| Infant number | Organism | Diagnosis at admission | GA | Birth weight | Date of isolation | Day of life | Outcome |
|---|---|---|---|---|---|---|---|
| 1 | Acinetobacter S- colistin | MAS, pneumothorax | 40 | 3090 | 8/10/18 | 2 | • Expired • Source of outbreak |
| 2 | Acinetobacter S- colistin | Very preterm, RDS | 29+2 | 1200 | 16/10/18 | 6 | • Expired • CLABSI |
| 3 | Acinetobacter S- colistin | Perinatal asphyxia, HIE 2 | 40 | 2500 | 15/10/18 | 5 | • Expired • CLABSI • VAP |
| 4 | Acinetobacter S- colistin | Congenital diaphragmatic hernia | 39 | 2900 | 17/10/18 | 5 | Discharged |
| 5 | Acinetobacter S- colistin | Moderate preterm, perinatal asphyxia, subgaleal bleed | 32+4 | 1960 | 24/10/18 | 11 | • Expired • VAP • CLABSI |
| Source | • Infant 1 was index case • The culture was traced only after the outbreak • The spreading of infection was due to poor hand hygiene, lack of bundle care, • This was attributed to an acute severe shortage of nurses in the unit | ||||||
| Action | • Cohorting of neonates • Education of HCP on CLABSI • Ensures all HCP re-read the protocol • Re-teaching how to prepare IV fluids (prevent sharing of vials across beds) • Strengthening Housekeeping and cleaning policy • Counseling of family • Increase of nurse-infant ratio • Use of colistin in infant who is showing sudden worsening during this period (one baby had received without culture positivity). | ||||||
CLABSI Central line associated blood stream infection; GA Gestational age; HCP Health care personnel; HIE Hypoxic ischemic encephalopathy; IV Intravenous; MCA Meconium aspiration syndrome; MDR Multi-drug resistant; RDS Respiratory distress syndrome; VAP Ventilator-associated pneumonia